MHLW Preapproves Takeda's Vectibix For Colorectal Cancer
This article was originally published in PharmAsia News
Executive Summary
The Second Committee on New Drugs at the Ministry of Health, Labor and Welfare Feb. 22 recommended Takeda monoclonal antibody drug Vectibix (panitumumab) intravenous injection